Humana Inc. (NYSE:HUM – Get Free Report) shares gapped down prior to trading on Tuesday after Truist Financial lowered their price target on the stock from $325.00 to $305.00. The stock had previously closed at $252.86, but opened at $244.43. Truist Financial currently has a hold rating on the stock. Humana shares last traded at $235.74, with a volume of 345,626 shares traded.
HUM has been the topic of several other research reports. JPMorgan Chase & Co. dropped their target price on shares of Humana from $257.00 to $256.00 and set a “neutral” rating on the stock in a research report on Tuesday, February 18th. Barclays raised their price objective on shares of Humana from $270.00 to $322.00 and gave the stock an “equal weight” rating in a research report on Friday, April 11th. Piper Sandler raised their price objective on shares of Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a research note on Wednesday, January 15th. Oppenheimer raised their price objective on shares of Humana from $300.00 to $310.00 and gave the company an “outperform” rating in a research note on Thursday, May 1st. Finally, Raymond James upgraded shares of Humana from a “market perform” rating to an “outperform” rating and set a $315.00 price objective for the company in a research report on Thursday, May 1st. Seventeen investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $286.81.
Get Our Latest Stock Report on HUM
Institutional Inflows and Outflows
Humana Trading Down 6.8%
The company has a market capitalization of $28.45 billion, a PE ratio of 23.71, a price-to-earnings-growth ratio of 2.05 and a beta of 0.49. The company’s fifty day moving average is $265.02 and its 200-day moving average is $270.41. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76.
Humana (NYSE:HUM – Get Free Report) last announced its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share for the quarter, beating analysts’ consensus estimates of $10.07 by $1.51. Humana had a net margin of 1.02% and a return on equity of 11.70%. The firm had revenue of $32.11 billion for the quarter, compared to analyst estimates of $32 billion. During the same period in the previous year, the company earned $7.23 earnings per share. The business’s quarterly revenue was up 8.4% compared to the same quarter last year. On average, analysts anticipate that Humana Inc. will post 16.47 EPS for the current fiscal year.
Humana Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.50%. The ex-dividend date is Friday, June 27th. Humana’s dividend payout ratio is presently 25.04%.
Humana Company Profile
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
See Also
- Five stocks we like better than Humana
- What is the S&P/TSX Index?
- 3 Huge S&P 500 Winners From Trump Trade Deal & The Biggest Loser
- Business Services Stocks Investing
- Why SoundHound’s Growth and Zero Debt Are a Bullish Signal
- Stock Sentiment Analysis: How it Works
- Best Biotech Stocks to Buy in 2025
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.